Call Support +91-85588-96644
TCYonline

Login

Sign Up

Please enter a Username or Email ID
Please enter a password
Keep me logged in
Please enter your name
Please enter your mobile number
You can't leave Captcha Code empty
By submitting this form, you agree to the Terms & Privacy Policy.
OR

Sign Up via Facebook

Sign Up via Google

Sign Up via Twitter

Download Software
Tests given

Download TCY App

App Image
 
loading

GENDER/ HEALTH/ EDUCATION - January 2019

Jan 2019

May 01, 2020

CSIR Identifies top 25 Drugs, Drug Candidates for Repurposing

  • To provide drugs for Coronavirus patients in India, Council of Scientific and Industrial Research (CSIR) has  identified the top 25 drugs and drug candidates for repurposing. 
  • Among these top 25 drugs, Favipiravir a broad spectrum inhibitor of viral RNA polymerase has emerged as of one of the most promising drugs.
  • Favipiravir was developed by Fujifilm Toyama Chemical Ltd., and is an approved treatment for common influenza and is marketed in Russia, China and Japan.
  • CSIR-IICT, based in Hyderabad has developed a convenient and cost effective synthetic process for Favipiravir.

Apr 29, 2020

G-20 launches access to COVID-19 Tools Accelerator" Initiative

  • The Saudi G20 Presidency has welcome the launch of "Access to COVID-19 Tools (ACT) Accelerator", a landmark, global and timely collaboration for the accelerated development, production and equitable access to new COVID-19 tools.
  • The ACT Accelerator initiative will be a global platform for action to enhance connections and leverage interdependencies for collective partnership, problem-solving, mobilizing and guiding investments, and driving equitable access for new COVID-19 diagnostics, therapeutics and vaccines.

Apr 28, 2020

Coronavirus Vaccine Likely By September, Says Pune's Serum Institute

  • Serum Institute of India will be manufacturing Oxford University's coronavirus vaccine in anticipation of clinical trials succeeding by September-October, 2020 in the UK.
  • Vaccine major Serum Institute of India said it plans to start production of the COVID-19 vaccine developed by Oxford University.
  • The Pune-based company has partnered with Oxford University as one of the seven global institutions manufacturing the vaccine.

Apr 27, 2020

IIT Kharagpur Ranked 57th in THE's 2nd Edition Of Impact Rankings 2020

  • According to Times Higher Education (THE)'s 2nd edition of Impact rankings 2020, which has ranked 766 universities from 85 countries, The Indian Institute of Technology (IIT) Kharagpur is ranked 57th with a score of 87.9 among global universities.
  • The list is topped by the University of Auckland, New Zealand with a score of 98.5, followed by  University of Sydney (98.1), Western Sydney University(97.9) in Australia.

King George Medical University in Lucknow Becomes 1st Govt Hospital In Country To Successfully La...

  • The King George Medical University in Uttar Pradesh has become the first government hospital in the country to successfully launch the plasma therapy treatment for the COVID-19 patients. 
  • First dose of the plasma therapy was given to a 58-year old patient.

Apr 25, 2020

NASA Develops New Ventilator Tailored Specifically To Treat COVID-19 Patients

  • NASA engineers have developed a new, easy-to-build high-pressure ventilator tailored specifically to treat COVID-19 patients.  The US space agency said that the device, called VITAL (Ventilator Intervention Technology Accessible Locally), passed a critical test at the Icahn School of Medicine in New York, an epicentre of COVID-19 in the US. 
  • NASA added that VITAL is designed to treat patients with milder symptoms, thereby keeping country's limited supply of traditional ventilators available for patients with more severe COVID-19 symptoms.

Shilpa Medicare Share Price Gains Nearly 3% On Launch Of Anti-Cancer Drug

  • The company has launched the Indian branded generic of Dasatinib, an anticancer drug with a brand name "DASASHIL".
  •  Shilpa Medicare share price rose nearly 3 percent in early trade on April 24, 2020  after the company launched its anti-cancer drug.
  • The drug is available with all dosage strength 20/ 50/ 70/ 100 mg tablets, used for the treatment of Chronic Myeloid Leukaemia (CML).
Share on
Keep Yourself updated on Latest PTE Exam Pattern

Avail Free Topic-wise Tests and various other offers.